MedPath

Goals for Epilepsy Clinic Visits Trial

Not Applicable
Recruiting
Conditions
Drug Resistant Epilepsy
Interventions
Behavioral: Questionnaires for Providers
Behavioral: Survey questionnaires
Behavioral: Epilepsy Visit Planner
Registration Number
NCT05928598
Lead Sponsor
University of Michigan
Brief Summary

The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool.

The project's hypotheses are:

* Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group.

* Patients that receive the Epilepsy Visit Planner will have improved quality of life scores.

* The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study.

Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
162
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Intervention arm (Epilepsy Visit Planner) - provider participantsQuestionnaires for ProvidersEpilepsy providers will be recruited from the University of Michigan (approximately 10 providers).
Intervention arm (Epilepsy Visit Planner) - patient participantsSurvey questionnairesThis group will be enrolled after the standard care arm enrollment is completed.
Standard care arm - patient participantsSurvey questionnairesThis group will be enrolled first.
Intervention arm (Epilepsy Visit Planner) - patient participantsEpilepsy Visit PlannerThis group will be enrolled after the standard care arm enrollment is completed.
Primary Outcome Measures
NameTimeMethod
Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI), difference in mean score between trial armsBaseline

This is a 10-item measure with Likert scale (range 1-5 for each response) with a score range of 10-50 (higher score indicating higher perceived efficacy in communicating with providers).

Secondary Outcome Measures
NameTimeMethod
Acceptability of Intervention Measure, assessed in intervention armBaseline - intervention arm only

There are 4 questions that will be completed by the patient participants and provider participants that evaluate the acceptability of the intervention. The question responses have a Likert scale from 1(completely disagree) to 5 (completely agree). There is a range from 5-25 with a higher score indicating a higher acceptability of the intervention tool.

Quality of Life in Epilepsy (QOLIE-10) inventory, difference in mean score between trial arms3 months after baseline visit

This is a 10-item measure with Likert scale (range 1-5 for each response) with a score range of 10-50 (lower score indicates better health outcome).

Perceived Involvement in Care (PICS), difference in mean score between trial armsBaseline

This is a 13-item measure with binary agree/disagree responses (0 points for disagree and 1 point for agree) and higher scores reflecting a greater degree of perceived patient activity and involvement.

Feasibility, assessed in intervention armBaseline - intervention arm only

Three questions will be asked regarding if the Planner was completed, if the Planner was shared during the visit, and how the Planner impacted visit length. Both patient participants and provider participants will complete these questions.

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath